≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Pancreas

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_PANCREAS

Malignant Pancreatic Neoplasm: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D13.6&
  • Hospital discharge: ICD-9 — 2116
  • Hospital discharge: ICD-8 — 21160
  • Cause of death: ICD-10 — D13.6&
  • Cause of death: ICD-9 — 2116
  • Cause of death: ICD-8 — 21160

2 out of 7 registries used, show all original rules.

857

4. Check minimum number of events

None

857

5. Include endpoints

None

857

6. Filter based on genotype QC (FinnGen only)

857

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D13
Name in latin
Neoplasma benignum pancreatis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4049 2363 1645
Only index persons 3590 2126 1464
Unadjusted period prevalence (%)
Whole population 0.06 0.07 0.05
Only index persons 0.07 0.08 0.06
Median age at first event (years)
Whole population 69.61 70.03 69.18
Only index persons 69.51 69.68 69.25

-FinnGen-

Key figures

All Female Male
Number of individuals 857 490 367
Unadjusted period prevalence (%) 0.16 0.17 0.16
Median age at first event (years) 69.48 68.35 71.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
715
Matched controls
7151
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
4503599627370496.0
323.0
704
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
69.7
302.3
343
93
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
28.9
89.7
123
51
K86.2
ICD-10 Finland
Cyst of pancreas
65.8
88.8
102
18
A09AA02
ATC
multienzymes (lipase, protease etc.)
24.0
82.2
119
59
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
33.8
74.0
97
33
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
16.4
67.7
112
80
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
93.8
62.1
68
8
JLC30
NOMESCO Finland
Pancreatoduodenectomy
50.7
57.6
69
15
JLC10
NOMESCO Finland
Distal pancreatectomy
128.3
55.7
59
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.8
48.1
117
174
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
32.7
48.0
63
21
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
41.0
39
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.2
39.8
77
76
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
22.4
38.5
56
27
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
44.6
37.6
46
11
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
17.2
35.2
56
35
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
19.9
34.5
52
28
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.5
33.5
82
121
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
32.8
329
1722
UJK02
NOMESCO Finland
ERCP
8.2
28.4
65
86
WZC30
NOMESCO Finland
Teaching
3.2
28.0
168
621
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.6
26.7
98
237
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.6
25.7
94
227
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
60.3
25.2
29
5
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
25.0
179
740
Z71.8
ICD-10 Finland
Other specified counselling
2.6
24.7
217
1015
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
24.0
136
476
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
22.6
99
282
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
10.1
22.6
45
47
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
22.1
283
1593
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
82.7
21.8
24
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
21.0
108
351
ZX120
NOMESCO Finland
Intravenous
3.3
20.2
112
385
K83.0
ICD-10 Finland
Cholangitis
11.8
20.2
37
33
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
11.4
19.9
37
34
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
19.5
121
447
K83.1
ICD-10 Finland
Obstruction of bile duct
9.5
19.1
39
43
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
19.1
79
214
B01AB10
ATC
tinzaparin; parenteral
3.6
18.8
88
265
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.8
18.7
34
30
JMA10
NOMESCO Finland
Transabdominal total splenectomy
20.0
18.3
27
14
N02BE01
ATC
paracetamol; systemic, rectal
2.7
17.1
645
5526
K86.3
ICD-10 Finland
Pseudocyst of pancreas
26.3
17.0
23
9
WX402
NOMESCO Finland
General anaesthesia
2.5
16.8
146
660
R4190
NOMESCO Finland
Nutritional therapy
6.2
16.3
44
75
UJF32
NOMESCO Finland
Coloscopy
2.1
16.2
239
1388
B01AB05
ATC
enoxaparin; parenteral
2.0
15.5
269
1660
RD211
NOMESCO Finland
NA
4.1
15.5
62
163
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
11.6
15.4
28
25
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
7.9
15.0
34
45
K85.8
ICD-10 Finland
Other acute pancreatitis
18.9
14.8
22
12
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
14.6
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
14.6
133
615
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
10.4
14.6
28
28
A02BC02
ATC
pantoprazole; systemic
1.9
14.5
502
3936
K86.1
ICD-10 Finland
Other chronic pancreatitis
12.9
14.5
25
20
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.3
14.3
75
247
K86.8
ICD-10 Finland
Other specified diseases of pancreas
18.0
13.9
21
12
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
12.4
13.7
24
20
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
76.6
13.6
15
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
142.5
13.5
14
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
6.6
13.4
34
54
JN4CD
NOMESCO Finland
Very extensive body CT
3.7
13.2
59
171
130
Kela drug reimbursment
Malignant tumour
2.7
13.2
94
375
XX3DW
NOMESCO Finland
Time consuming IT work
2.5
12.9
108
475
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
7.4
12.9
30
42
Z3231
NOMESCO Finland
Registered nurse
1.9
12.8
227
1387
JAH01
NOMESCO Finland
Laparoscopy
3.9
12.7
53
145
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
15.8
12.7
20
13
R50.9
ICD-10 Finland
Fever, unspecified
2.3
12.7
123
582
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
20.5
12.5
18
9
R4110
NOMESCO Finland
Physiotherapy
1.9
12.1
220
1357
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
47.5
11.9
14
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
11.0
171
989
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
10.6
288
2005
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
14.5
10.5
17
12
J01MA12
ATC
levofloxacin; systemic
2.0
10.4
158
906
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
10.2
135
730
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
10.1
217
1400
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
10.1
172
1026
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
10.0
198
1242
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
40.6
10.0
12
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.9
324
2365
J01MA02
ATC
ciprofloxacin; systemic
1.7
9.8
293
2084
Z00.0
ICD-10 Finland
General medical examination
2.0
9.8
143
805
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
9.7
202
1288
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.6
9.6
27
50
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.1
9.6
25
42
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
15.3
9.5
15
10
UJK12
NOMESCO Finland
Peroral cholangioscopy
30.4
9.4
12
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.2
9.4
102
508
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
8.8
9.3
19
22
JAH00
NOMESCO Finland
Laparotomy
4.4
9.2
32
75
N02AA05
ATC
oxycodone; systemic
2.0
9.1
127
699
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
9.1
118
633
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
18.9
9.0
13
7
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
24.3
8.9
12
5
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
8.8
156
937
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.8
160
971
A05AA02
ATC
ursodeoxycholic acid; oral
6.3
8.7
22
36
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
8.6
93
463
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
11.7
8.6
15
13
K85
ICD-10 Finland
Acute pancreatitis
5.0
8.6
26
53
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
16.5
8.6
13
8
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
8.5
213
1425
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
27.9
8.5
11
*
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
20.3
8.5
12
6
UJF92
NOMESCO Finland
Capsular endoscopy
5.4
8.4
24
46
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
+∞
8.3
8
*
T90
ICPC
Diabetes non-insulin dependent
1.7
8.3
189
1230
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
8.2
53
202
J01DB01
ATC
cefalexin; oral
1.7
8.2
566
4933
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
17.4
8.1
12
7
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
13.2
7.9
13
10
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
7.8
63
272
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
7.8
93
482
R53
ICD-10 Finland
Malaise and fatigue
1.8
7.7
153
951
L01BC06
ATC
capecitabine; oral
3.2
7.7
39
127
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.7
168
1075
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.6
7.6
53
212
A02BC05
ATC
esomeprazole; systemic
1.6
7.4
300
2261
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
13.5
7.4
12
9
-1
NOMESCO Finland
NA
1.6
7.3
209
1441
SPAT1252
SPAT
Overall medication plan or its review
2.3
7.2
65
297
ZYC01
NOMESCO Finland
Remote contact by phone
3.1
7.2
37
122
A10AE04
ATC
insulin glargine; parenteral
2.2
7.2
76
372
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
7.1
80
403
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.4
7.1
32
96
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
7.1
45
169
C07AB07
ATC
bisoprolol; oral
1.5
7.1
363
2882
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
4.6
6.8
22
49
K59.09
ICD-10 Finland
Constipation, unspecified
2.4
6.8
54
232
ZXE00
NOMESCO Finland
One hour or less
1.5
6.8
283
2134
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
6.2
6.8
17
28
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
40.4
6.8
8
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
2.5
6.7
51
216
JN4BD
NOMESCO Finland
Extensive body CT
1.9
6.6
100
568
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
12.4
6.6
11
9
A10BA02
ATC
metformin; oral
1.6
6.5
207
1465
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.5
6.4
48
198
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
6.4
237
1730
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
70.4
6.4
7
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.9
6.3
24
63
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
6.3
279
2124
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.6
6.3
42
165
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
6.3
6
*
158
Kela drug reimbursment
Everolimus
+∞
6.3
6
*
JLB35
NOMESCO Finland
Transduodenal endoscopic extraction of foreign body from pancreatic duct
+∞
6.3
6
*
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
26.9
6.2
8
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.2
121
747
SPAT1262
SPAT
Handing over of treatment supplies
1.7
6.1
146
952
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
6.1
99
576
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
10.1
6.0
11
11
D76
ICPC
Malignant neoplasm pancreas
10.1
6.0
11
11
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
6.0
66
332

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
341
167
33.25
307.65
3.3
3.7
u/ml
41.1
2199.6
0.83
315
159
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
305
329
13.84
272.42
4.5
3.3
u/ml
76.9
4332.6
0.79
273
281
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
433
892
8.79
226.27
3.6
4.2
ug/l
2.8
25.9
1.79
363
741
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
317
753
6.09
134.62
2.9
2.1
g/l
0.2
0.2
6.59
309
707
(3000570) Elastase.pancreatic [Mass/mass] in Stool
172
248
8.43
117.84
1.6
1.5
ug/g
218.6
280.5
2.70
127
147
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
570
2408
5.08
116.59
4.1
2.4
u/l
64.0
57.4
0.78
552
2203
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
305
846
5.04
105.31
4.1
2.8
umol/l
6.3
8.4
1.63
275
740
(3021162) Amylase [Enzymatic activity/volume] in Specimen
55
14
41.91
90.63
4.2
2.2
u/l
1917.7
5718.3
0.44
55
14
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
714
4052
5.57
88.96
10.5
6.4
umol/l
11.0
11.5
0.56
700
3839
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
246
683
4.65
82.76
4.9
2.3
u/l
244.6
35.9
1.34
222
570
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
67
7
103.72
61.83
3.2
2.7
pmol/l
68.2
39.9
—
54
7
(3024561) Albumin [Mass/volume] in Serum or Plasma
597
3432
3.44
61.69
8.2
4.8
g/l
34.4
35.1
2.45
584
3193
(3032080) INR in Blood by Coagulation assay
582
3310
3.36
60.92
10.5
10.0
inr
1.2
1.3
1.47
248
922
(3021589) Normoblasts [#/volume] in Blood
559
3276
3.03
52.15
16.6
9.9
e9/l
0.0
0.0
0.25
489
2691
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
792
5859
5.64
48.11
13.9
7.7
u/l
86.0
79.1
2.89
779
5464
(3013826) Glucose [Moles/volume] in Serum or Plasma
667
4514
3.15
44.28
6.8
4.9
mmol/l
7.0
6.8
2.02
652
4262
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
411
2333
2.46
36.24
4.4
3.3
u/l
34.1
32.9
0.25
400
2208
(3026782) Osmolality of Urine
311
1569
2.54
35.22
3.8
2.9
mosm/kgh2o
513.6
548.8
2.24
286
1337
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
173
667
3.00
32.92
5.1
3.5
mmol/l
1.2
1.2
0.07
165
584
(3002582) Erythrocytes [#/volume] in Urine
408
2387
2.35
32.63
4.3
3.3
e6/l
58.2
96.6
0.50
344
1869
(3033658) Prothrombin time (PT) actual/Normal
347
1906
2.38
31.94
6.7
3.9
%
89.0
88.5
0.12
341
1865
(3025159) Blasts/100 leukocytes in Blood
155
588
3.00
30.19
5.0
4.2
%
0.0
0.7
0.59
30
152
(40768797) Stomach Pathology biopsy report
233
1097
2.54
29.80
1.6
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
160
623
2.93
29.71
4.8
4.1
%
0.2
0.1
0.51
34
179
(3017181) Myelocytes/100 leukocytes in Blood
166
662
2.87
29.48
4.8
4.0
%
1.0
0.9
0.19
35
196
(3030467) Casts [#/volume] in Urine by Automated count
375
2199
2.25
28.87
4.1
3.2
e6/l
0.5
0.5
0.03
313
1689
(3018095) Leukocytes [#/volume] in Urine
437
2738
2.22
28.43
5.4
3.8
e6/l
94.5
83.1
0.17
359
1998
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
448
2841
2.21
28.21
4.3
3.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
595
4263
2.29
27.22
11.9
9.2
e9/l
4.5
4.1
2.32
546
3743
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
562
3955
2.22
26.55
8.8
6.9
mmol/l
1.2
1.2
0.22
468
3348
(3018677) aPTT in Platelet poor plasma by Coagulation assay
245
1241
2.36
26.26
2.5
2.0
s
30.2
29.7
0.64
240
1199
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
43
69
6.51
25.93
1.7
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
386
2365
2.15
25.86
5.7
4.1
ph
7.4
7.4
1.44
142
444
(36304419) Bacteria [Presence] in Urine
356
2117
2.17
25.73
4.1
3.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
53
106
5.26
25.46
1.8
1.5
g/l
0.5
0.7
1.16
33
80
(3003458) Phosphate [Moles/volume] in Serum or Plasma
213
1030
2.42
25.23
6.5
5.5
mmol/l
1.0
1.0
0.82
206
941
(3000850) Epithelial cells [#/volume] in Urine
300
1679
2.21
25.16
3.4
2.6
e6/l
5.5
5.2
0.16
262
1493
(3002179) Metamyelocytes/100 leukocytes in Blood
147
596
2.77
25.05
4.7
3.9
%
0.6
0.5
0.08
28
143
(3012095) Magnesium [Moles/volume] in Serum or Plasma
245
1276
2.29
24.36
3.5
3.3
mmol/l
0.8
0.8
0.62
232
1185
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
508
3516
2.09
23.98
5.8
4.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
360
2198
2.10
23.83
6.7
4.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
728
5843
2.63
23.46
32.1
19.6
%
14.0
13.8
3.19
722
5718
(3029937) Albumin [Presence] in Urine by Test strip
334
1997
2.10
23.25
5.1
4.2
estimate
0.0
0.0
0.50
182
648
(3044889) 12 lead EKG panel
684
5380
2.34
22.33
5.1
4.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
515
3638
2.04
22.31
7.9
6.0
mmol/l
1.2
1.2
1.24
498
3275
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
70
200
3.72
21.33
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
444
3029
1.97
20.64
2.8
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
267
1526
2.09
20.46
5.3
4.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
310
1884
2.01
19.97
8.7
6.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
60
163
3.88
19.64
4.2
4.4
mmol/l
2.9
2.7
0.21
47
109
(3006315) Basophils [#/volume] in Blood
505
3656
1.93
19.07
7.1
5.7
e9/l
0.0
0.0
1.53
446
3144
(3001604) Monocytes [#/volume] in Blood
503
3641
1.92
18.96
7.1
5.7
e9/l
0.6
0.6
1.92
445
3118
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
43
95
4.71
18.39
1.7
1.3
nmol/l
0.6
0.6
0.76
38
89
(3005719) IgG [Mass/volume] in Serum or Plasma
129
570
2.49
18.18
3.2
2.8
g/l
10.5
10.6
0.12
112
518
(3019069) Monocytes/100 leukocytes in Blood
479
3450
1.88
17.93
7.1
6.2
%
8.8
8.7
0.16
460
3215
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
41
89
4.79
17.91
1.6
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
467
3339
1.88
17.86
7.1
5.9
%
0.7
0.7
0.11
450
3104
(3019198) Lymphocytes [#/volume] in Blood
507
3722
1.89
17.83
7.2
5.8
e9/l
1.9
1.9
0.12
454
3251
(4035726)
147
698
2.34
17.63
1.4
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
497
3634
1.88
17.61
5.6
5.3
estimate
0.0
0.0
0.00
187
676
(3035350) Ketones [Presence] in Urine by Test strip
495
3621
1.87
17.45
4.6
3.9
estimate
0.0
0.0
0.00
183
681
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
225
1271
2.04
17.39
3.4
3.0
e6/l
2.2
2.2
0.02
136
716
(3006504) Eosinophils/100 leukocytes in Blood
475
3436
1.86
17.29
7.1
5.9
%
2.7
2.8
0.57
457
3189
(3013115) Eosinophils [#/volume] in Blood
510
3773
1.87
17.27
7.4
5.9
e9/l
0.2
0.2
0.56
458
3301
(3041096) Erythrocytes [Presence] in Urine by Automated
305
1923
1.91
17.09
4.4
3.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
207
1144
2.07
16.93
3.5
2.5
g/l
2.3
2.3
0.17
195
1060
(3009261) Glucose [Presence] in Urine by Test strip
499
3683
1.85
16.84
4.6
3.9
estimate
0.0
0.0
0.00
185
658
(3002030) Lymphocytes/100 leukocytes in Blood
480
3508
1.84
16.65
7.2
6.1
%
26.1
27.0
1.04
458
3251
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
68
224
3.21
16.61
2.3
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
196
1078
2.06
16.17
3.7
2.5
%
22.7
22.2
0.15
180
917
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
433
3088
1.81
16.08
2.8
2.2
nmol/l
79.4
78.7
0.22
411
2701
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
38
85
4.63
16.02
1.7
1.3
nmol/l
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
629
5051
1.92
15.65
5.8
4.7
e6/l
44.0
3156.3
—
6
87
(3002256) Pathology report gross observation
179
964
2.08
15.57
1.5
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
17
10.18
14.95
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
17
10.18
14.95
1.1
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
467
3455
1.77
14.88
6.9
5.8
%
58.8
57.8
1.00
448
3225
(3022948) Iron [Moles/volume] in Serum or Plasma
212
1242
1.94
14.44
3.5
2.5
umol/l
12.4
12.7
0.23
200
1145
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
806
7197
3.01
14.20
27.7
15.7
mg/l
29.2
24.9
2.77
715
5767
(3022145) Colonoscopy Study observation
161
861
2.07
14.17
1.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
282
1824
1.81
14.02
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
389
2785
1.73
13.45
4.7
4.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
156
844
2.04
13.24
4.6
3.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
108
509
2.28
13.02
8.4
9.1
%
94.7
94.0
0.67
108
504
(3044640) Blood type and Crossmatch panel - Blood
346
2417
1.72
12.94
3.3
2.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
414
3050
1.69
12.63
4.3
3.9
ng/l
40.0
48.6
0.19
309
2288
(3042936) Bacteria identified in Isolate by Culture
195
1159
1.88
12.52
2.8
2.0
—
—
—
0
0
(4062490)
28
64
4.49
11.51
1.4
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
131
699
2.03
11.47
8.5
7.3
mmol/l
9.8
10.2
0.33
123
664
(3020891) Body temperature
77
332
2.45
11.33
6.1
4.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
348
2504
1.66
11.23
3.4
3.2
mmol/l
6.5
7.1
1.88
305
2052
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
557
4514
1.67
11.17
4.6
3.2
u/l
73.7
52.5
2.36
532
4150
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
770
6883
2.17
10.87
26.8
14.8
ml/min/173m2
75.7
76.1
0.27
725
5681
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
239
1569
1.73
10.82
4.0
3.2
mmol/l
2.5
2.5
1.33
217
1389
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1328
1.76
10.59
1.9
1.5
g/l
2.6
2.5
0.22
153
765
(3027135) IgG subclass 1 [Mass/volume] in Serum
26
61
4.36
10.36
1.5
1.3
g/l
6.4
7.5
—
10
44
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
61
4.36
10.36
1.5
1.3
g/l
2.7
2.7
—
10
44
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
61
4.36
10.36
1.5
1.3
g/l
0.3
0.4
—
10
43
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
115
607
2.03
10.34
2.7
2.8
ml/min/173m2
68.7
61.4
1.18
57
259
(42870588) Differential panel, method unspecified - Blood
347
2534
1.62
10.32
6.9
5.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
353
2601
1.61
10.05
4.3
4.0
mg/mmol
6.6
8.4
0.73
241
1606
(40761536) Microorganisms panel - Urine sediment
117
630
1.99
9.94
4.7
4.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
44
155
2.94
9.62
4.0
3.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
28
74
3.88
9.56
1.3
1.2
u/l
62.4
49.5
0.79
23
53
(3013707) Erythrocyte sedimentation rate by Westergren method
646
5534
1.68
9.55
5.5
4.3
mm/h
15.2
13.4
1.86
620
5065
(3001122) Ferritin [Mass/volume] in Serum or Plasma
400
3063
1.57
9.51
4.3
2.8
ug/l
132.5
143.4
0.50
383
2782
(40768441) Liver Pathology biopsy report
25
62
4.12
9.29
1.2
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
35
110
3.27
9.27
1.7
2.1
pg
32.1
32.4
0.15
35
110
(3015377) Calcium [Moles/volume] in Serum or Plasma
363
2730
1.57
9.26
4.3
3.6
mmol/l
2.4
2.4
0.02
343
2353
(3012516) Albumin [Mass/volume] in Urine
333
2456
1.58
9.24
3.4
3.3
mg/l
411.9
244.9
0.27
231
1532
(3026008) Bacteria identified in Urine by Culture
339
2512
1.58
9.21
4.0
3.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
39
134
3.00
8.92
2.9
2.8
e9/l
4.5
4.5
0.03
39
134
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
1026
0.39
8.88
4.6
4.8
%
34.8
32.6
0.57
35
665
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
140
2.95
8.86
3.3
3.1
%
57.0
59.4
0.64
40
140
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
28
5.80
8.83
1.5
1.3
umol/l
29.3
30.5
0.15
16
28
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
236
1619
1.63
8.77
2.0
1.7
mg/l
1.5
1.3
0.36
184
1280
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
50
200
2.59
8.62
3.3
2.6
g/l
3.9
3.6
0.55
50
190
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
104
568
1.95
8.45
1.7
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
29
86
3.46
8.41
2.4
1.3
mu/l
43.6
40.4
0.05
23
80
(3022217) INR in Platelet poor plasma by Coagulation assay
169
1073
1.72
8.41
24.3
28.1
inr
1.6
1.3
1.09
17
139
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
280
2020
1.57
8.37
2.8
2.2
mg/l
3.4
3.1
0.92
253
1719
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
48
192
2.59
8.29
1.8
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
37
129
2.95
8.26
4.8
2.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
276
2.30
8.08
2.8
2.5
u/ml
0.2
0.4
6.62
38
156
(3022689) Creatine [Moles/volume] in Urine
13
20
6.58
8.08
2.0
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
603
5164
1.57
8.05
5.4
4.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
26
75
3.54
7.87
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
275
2013
1.54
7.56
3.7
2.8
umol/l
2081.9
8109.5
2.28
252
1714
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
25
5.68
7.56
2.0
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
112
654
1.82
7.39
10.2
8.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
146
921
1.71
7.38
1.4
1.3
titre
633.1
495.5
0.31
29
217
(3023103) Potassium [Moles/volume] in Serum or Plasma
814
7618
2.37
7.36
31.0
18.8
mmol/l
4.0
4.0
0.57
809
7402
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
315
2.15
7.31
2.5
2.7
g/l
2.9
3.1
1.00
43
249
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
122
2.86
7.24
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
148
942
1.69
7.23
2.0
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
49
212
2.39
7.20
1.3
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
20
51
3.99
7.19
3.0
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
193
1320
1.60
7.09
2.0
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
198
1364
1.59
7.05
3.2
2.8
e6/l
1.3
1.1
0.30
107
803
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
61
293
2.16
7.02
2.7
2.9
g/l
0.9
1.3
0.45
53
257
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
165
2.56
7.02
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
753
6885
1.77
6.96
7.9
6.4
mmol/mol
42.1
40.5
4.33
736
6318
(3004588) Protein electrophoresis panel - Serum or Plasma
105
614
1.81
6.89
2.4
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
146
940
1.67
6.81
2.0
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
55
259
2.20
6.66
2.9
2.8
g/l
0.0
0.0
0.06
49
238
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
50
3.86
6.56
1.0
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
117
717
1.73
6.54
3.0
3.0
g/l
66.4
66.3
0.05
111
645
(3021879) Hepatitis B virus core Ab [Presence] in Serum
77
415
1.94
6.51
1.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
55
3.70
6.50
1.5
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
115
703
1.73
6.49
7.2
6.9
mmol/l
1.3
1.4
0.75
106
673
(3000034) Microalbumin [Mass/volume] in Urine
24
75
3.26
6.46
3.8
3.4
mg/l
30.0
14.9
0.69
17
60
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
712
1.73
6.45
1.7
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
107
643
1.76
6.41
1.7
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
146
965
1.62
6.12
8.0
7.2
mmol/l
0.8
1.3
1.02
119
748
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
340
1.99
6.00
2.5
2.6
g/l
3.7
3.7
0.02
43
246
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
141
930
1.62
5.95
4.3
4.2
u/l
231.2
253.9
0.89
134
878
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
341
1.98
5.95
2.5
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
341
1.98
5.95
2.5
2.6
g/l
7.4
7.4
0.00
44
255
(3025941) Bacteria identified in Stool by Culture
71
386
1.92
5.86
1.4
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
149
2.48
5.85
6.2
6.5
iu/ml
256.7
183.6
—
6
19
(40767503) Oxygen content in Capillary blood by calculation
38
162
2.41
5.81
3.1
2.7
%
15.9
15.8
0.07
19
82
(3035637) Corticotropin [Mass/volume] in Plasma
23
75
3.12
5.80
1.8
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
89
522
1.79
5.79
9.5
8.7
%
1.2
1.3
1.02
89
517
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
50
3.66
5.78
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
794
7451
1.89
5.70
25.7
15.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
87
518
1.76
5.38
9.8
8.8
%
0.7
0.7
0.02
87
513
(46235355) HIV 1 and 2 tests - Meaningful Use set
126
831
1.61
5.31
1.8
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
74
422
1.82
5.29
3.5
2.8
e6/l
0.1
0.2
3.44
74
413
(3003181) Sodium [Moles/volume] in Urine
34
144
2.42
5.29
1.3
1.3
mmol/l
54.7
63.1
0.68
27
121
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
108
2.65
5.27
1.5
1.4
u/ml
91.2
108.4
—
5
16
(3045424) Erythrocytes [Presence] in Urine
29
114
2.60
5.26
2.0
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
210
1555
1.46
5.18
4.1
4.1
ng/l
245.3
360.9
0.33
168
1287
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
127
2.50
5.17
1.5
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
304
2412
1.40
5.12
2.3
2.2
u/l
133.6
222.0
1.93
294
2260
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
623
5588
1.42
4.91
4.4
3.9
pmol/l
15.1
15.0
0.61
587
4985
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
27
107
2.57
4.83
1.2
1.2
u/ml
322.7
342.6
0.09
21
60
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1505
1.45
4.79
1.3
1.2
u/ml
1.0
1.8
1.09
83
381
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
120
2.47
4.76
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
114
2.51
4.75
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
229
1751
1.42
4.70
1.9
1.7
pmol/l
451.9
15674193.1
1.31
193
1410
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
317
2565
1.37
4.65
2.8
3.1
ng/l
1323.9
1384.0
0.11
290
2198
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
52
278
1.93
4.56
2.9
4.0
ratio
1.6
1.9
0.15
14
22
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
382
1.79
4.52
3.0
3.0
pmol/l
4.5
4.5
0.14
60
329
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
51
273
1.92
4.46
2.7
2.6
g/l
37.9
37.3
0.40
43
234
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
30
4.04
4.44
2.2
2.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
281
1.91
4.42
3.0
4.1
mg/l
29.1
44.4
0.75
44
228
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
281
1.91
4.42
3.0
4.0
mg/l
36.5
78.6
1.14
44
226
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
238
1852
1.39
4.38
3.3
2.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
136
955
1.50
4.32
2.3
2.6
%
1.8
1.8
0.02
131
850
(3048689) Calprotectin [Mass/mass] in Stool
115
781
1.55
4.27
2.4
2.1
ug/g
171.1
133.3
0.69
96
611
(3026361) Erythrocytes [#/volume] in Blood
822
7891
2.02
4.17
39.6
23.4
e12/l
4.3
4.4
6.10
813
7650
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
97
2.52
4.16
1.3
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
822
7892
2.02
4.15
39.6
23.5
e9/l
7.1
6.7
4.52
813
7651
(3000963) Hemoglobin [Mass/volume] in Blood
822
7894
2.01
4.11
39.9
23.6
g/l
129.6
133.7
12.89
817
7755
(3037756) Immunofixation for Serum or Plasma
39
196
2.04
4.09
1.4
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
434
3741
1.32
4.00
2.7
2.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
821
7889
1.97
3.97
39.7
23.5
e9/l
253.9
245.5
2.68
814
7670
(3027923) C peptide [Moles/volume] in Serum or Plasma
13
38
3.46
3.91
1.6
1.4
nmol/l
0.9
1.0
0.33
13
29
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
94
2.49
3.91
1.2
1.1
iu/ml
28.2
111.3
—
5
15
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
34
3.57
3.77
4.2
4.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
75
474
1.64
3.77
1.6
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
40
210
1.95
3.74
2.9
4.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
61
2.82
3.70
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
717
6697
1.43
3.69
5.3
4.9
mu/l
1.9
2.2
0.77
682
6024
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
136
2.17
3.65
1.6
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
30
143
2.14
3.63
1.6
1.8
nmol/l
52.5
43.4
0.29
30
134
(3045414) Leukocytes [Presence] in Urine
55
325
1.74
3.56
2.2
1.9
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
46
258
1.83
3.54
2.3
1.6
titre
116.7
102.5
—
6
8
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
77
500
1.59
3.49
1.7
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
120
2.20
3.41
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
86
578
1.54
3.36
6.5
4.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
37
3.28
3.35
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
86
0.00
3.33
0.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
388
3353
1.29
3.29
2.4
2.1
pmol/l
89.2
95.3
2.28
240
1675
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
759
7199
1.47
3.27
5.6
5.0
mmol/l
6.2
6.0
3.34
726
6462
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
84
2.41
3.24
1.9
2.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
319
1.71
3.23
2.6
2.7
g/l
9.7
10.3
0.56
43
273
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
49
2.89
3.20
1.1
1.2
mmol/l
9.8
11.7
—
9
12
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
320
1.70
3.20
1.7
2.0
u/l
40.0
39.1
0.13
48
278
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
253
2075
1.31
3.16
1.7
1.7
mmol/l
1.4
1.4
0.74
218
1720
(3019225) pH of Specimen
52
828
0.60
3.15
4.0
4.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
43
246
1.79
3.13
2.9
2.8
g/l
0.0
0.0
0.00
38
225
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
20
4.54
3.12
1.0
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
102
724
1.46
3.09
2.6
2.7
e9/l
69.3
71.0
0.17
77
564
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
93
652
1.48
3.00
5.9
3.8
ng/l
83.9
92.2
0.44
78
565
(3004451) EKG impression Narrative
14
51
2.77
2.99
1.4
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
59
376
1.61
2.92
12.5
3.7
mmol/l
23.9
24.3
0.45
51
336
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
157
1.94
2.88
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
157
1.94
2.88
1.4
1.3
iu/l
37.9
30.7
0.44
23
138
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
23
109
2.14
2.86
10.4
5.6
mg/l
11.7
12.3
0.29
23
99
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
47
2.79
2.82
1.4
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
69
463
1.53
2.75
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
20
91
2.23
2.75
1.5
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
118
2.06
2.74
2.9
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
70
1010
0.67
2.73
15.6
7.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
38
219
1.77
2.73
1.2
1.5
g/l
0.2
0.2
0.03
38
209
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
14
54
2.62
2.71
1.0
1.0
mg/l
292.9
296.4
0.06
14
44
(3002032) Base excess in Venous blood by calculation
104
762
1.42
2.67
6.2
3.6
mmol/l
1.4
2.0
0.86
89
599
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
61
2.49
2.63
1.4
1.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
14
55
2.57
2.62
1.8
1.1
titre
98.0
92.0
—
5
10
(3047189) Immunofixation for 24 hour Urine
11
38
2.92
2.59
3.0
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
268
2268
1.26
2.55
2.9
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
33
3.05
2.53
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
379
0.49
2.53
1.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
88
2.19
2.52
2.7
2.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
242
2028
1.27
2.49
1.7
1.5
nmol/l
21.9
20.8
0.52
226
1689
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
109
2.05
2.48
2.0
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
57
2.48
2.46
3.3
3.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
21
103
2.06
2.43
1.7
2.0
%
91.3
89.5
1.49
21
103
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
282
1.63
2.42
2.3
3.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
12
5.03
2.40
6.5
7.0
mmol/l
4.9
6.1
—
6
12
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
8
6.28
2.37
3.8
6.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
22
3.66
2.36
1.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
46
2.63
2.36
1.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
84
2.17
2.36
2.2
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
64
442
1.48
2.27
10.2
9.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
157
1.81
2.24
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
157
1.81
2.24
1.4
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
37
227
1.66
2.18
1.3
1.5
g/l
1.1
1.2
0.30
37
217
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
19
3.71
2.15
1.0
1.2
iu/ml
88.6
138.2
—
7
19
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
91
679
1.38
2.14
1.6
1.7
%
1.7
1.5
0.63
74
564
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
244
1.63
2.14
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
207
1733
1.26
2.12
4.2
3.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
25
3.22
2.10
3.5
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
25
3.22
2.10
1.0
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
9
31
2.92
2.07
2.6
1.7
nmol/l
1.4
7.5
—
9
25
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
151
1220
1.29
2.07
1.4
1.3
iu/ml
31.5
36.9
0.29
52
384
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
61
427
1.46
2.04
9.4
9.6
mmol/l
24.0
24.5
0.81
56
399
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
185
1.70
2.03
1.7
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
36
224
1.63
2.02
1.3
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
232
1.62
2.02
1.3
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
32
2.83
2.00
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
32
2.83
2.00
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
119
1.87
1.98
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
60
422
1.45
1.97
2.3
2.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
234
1.61
1.96
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
27
2.98
1.94
1.3
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
16
3.77
1.93
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
117
924
1.31
1.90
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
51
351
1.48
1.87
3.5
2.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
34
2.66
1.87
2.6
2.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
183
1.66
1.84
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
160
1.71
1.83
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
191
1.65
1.83
1.7
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
12
4.18
1.82
2.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
231
1.58
1.81
1.3
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
29
176
1.67
1.81
1.4
2.7
umol/l
34.2
31.6
0.14
21
144
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
53
2.28
1.81
1.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
138
1.76
1.81
1.9
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
112
888
1.30
1.78
1.9
1.7
—
—
—
0
0
(3000492) Spirometry study
85
651
1.34
1.73
1.6
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
30
2.68
1.72
1.3
1.1
%
—
65.2
—
0
5
(40768800) Prostate Pathology biopsy report
29
180
1.63
1.68
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
161
0.43
1.68
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
55
2.20
1.68
1.0
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
212
1.58
1.67
1.5
1.6
iu/ml
0.4
0.1
—
10
41
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
759
7341
1.30
1.65
5.5
5.4
mmol/l
2.5
2.7
6.21
721
6670
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
55
396
1.42
1.63
1.9
1.9
g/l
1.4
1.5
0.55
48
348
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
14
3.59
1.61
1.0
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
14
70
2.02
1.60
1.5
1.3
%
22.4
32.0
—
8
44
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
286
0.55
1.59
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
129
1.72
1.58
1.3
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
11
50
2.22
1.57
1.1
1.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
57
2.12
1.55
1.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
24
145
1.67
1.55
5.5
2.1
%
65.6
61.2
0.40
24
145
(3020650) Glucose [Presence] in Urine
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
46
325
1.44
1.52
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
146
1.66
1.52
1.7
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
601
6303
0.84
1.46
27.8
17.5
%
39.1
39.0
0.17
448
4097
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
59
2.05
1.44
1.3
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
22
2.74
1.43
1.3
3.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
46
2.19
1.40
1.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
46
2.19
1.40
1.3
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
60
2.01
1.38
2.1
2.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
60
2.01
1.38
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
41
2.21
1.37
2.6
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
17
2.95
1.36
2.8
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
17
2.95
1.36
1.4
1.1
—
—
—
0
0
(3013512) EKG study
271
2426
1.17
1.35
4.2
4.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
14
75
1.88
1.35
1.5
1.7
u/l
15431.8
8253.8
—
6
18
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
75
1.88
1.35
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
112
923
1.25
1.34
1.9
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
40
0.00
1.33
0.0
2.6
—
—
—
0
0
(4281824)
15
83
1.82
1.32
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
712
6875
1.21
1.31
4.2
4.2
mmol/l
1.3
1.3
1.48
666
6184
(3021901) Oxygen saturation in Capillary blood
23
145
1.60
1.30
4.7
2.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
99
1.73
1.28
1.6
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
9
44
2.06
1.27
3.0
1.7
—
33.7
—
0
6
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
174
1509
1.19
1.26
3.4
3.3
ug/l
0.8
0.8
0.10
124
1064
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
115
1.67
1.25
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
229
1.46
1.23
2.9
3.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
19
2.64
1.21
1.2
1.6
pmol/l
15.8
14.2
—
5
13
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
112
934
1.23
1.21
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
429
0.69
1.21
1.7
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
417
0.68
1.21
3.6
3.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
117
1.64
1.19
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
117
1.64
1.19
1.9
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
39
2.06
1.15
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
36
0.00
1.14
0.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
54
416
1.32
1.12
1.3
1.2
u/ml
468.2
188.2
0.35
48
374
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
399
1.32
1.11
1.2
1.2
iu/ml
74.9
137.6
1.53
20
153
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
24
160
1.51
1.10
1.7
1.6
iu/l
4.2
5.7
—
10
47
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
81
1.74
1.09
2.3
2.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
66
1.83
1.09
1.8
1.6
%
11.9
10.6
0.54
12
66
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
5
21
2.39
1.09
3.2
3.2
%
76.6
71.8
—
5
16
(3019150) Specific gravity of Urine by Refractometry
183
1616
1.17
1.08
4.7
4.4
kg/l
1.0
1.0
0.07
16
243
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
162
1.50
1.05
1.6
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
136
1175
1.19
1.04
1.4
1.3
u/ml
9.9
13.3
0.28
64
408
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
46
1.97
1.03
2.0
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
47
1.92
1.02
4.0
3.0
—
—
—
0
0
(4010399)
45
583
0.76
1.02
1.7
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
10
53
1.90
1.01
1.1
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
48
1.88
1.00
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
27
189
1.44
1.00
1.3
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
175
0.57
0.99
1.8
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
84
1.68
0.98
1.4
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
21
140
1.51
0.98
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
43
328
1.33
0.97
1.4
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
18
117
1.55
0.94
2.1
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
102
0.49
0.90
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
103
0.48
0.89
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
103
0.48
0.89
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
104
0.48
0.89
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
104
0.48
0.89
1.2
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
79
1.66
0.88
1.5
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
186
1.41
0.88
6.0
2.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
16
103
1.56
0.88
1.4
1.4
%
54.3
59.4
—
9
68
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
112
1.53
0.85
1.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
45
1.78
0.84
2.8
2.6
%
13.9
13.3
—
8
45
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
735
7180
1.17
0.84
5.0
4.8
mmol/l
4.4
4.6
4.52
696
6557
(3006184) Hemoglobin [Mass/volume] in Capillary blood
24
172
1.41
0.81
3.3
2.4
g/l
128.2
127.5
0.04
18
127
(3008536) Aspergillus sp Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
25
0.00
0.79
0.0
1.2
—
56.6
—
0
11
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
98
1.54
0.79
2.5
3.6
—
—
—
0
0
(44790048)
14
90
1.56
0.78
2.2
1.7
—
—
—
0
0
(44806118)
14
90
1.56
0.78
2.2
1.7
—
—
—
0
0
(44790049)
14
90
1.56
0.78
2.2
1.7
—
—
—
0
0
(44790047)
14
90
1.56
0.78
2.2
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
222
0.67
0.78
1.5
1.8
mg/l
1.5
2.9
—
10
169
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
100
0.50
0.77
3.0
4.5
umol/l
310.0
364.6
—
5
88
(4015189)
0
27
0.00
0.77
0.0
3.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
87
746
1.19
0.76
1.6
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
166
1.40
0.76
1.2
1.2
e6/l
8.3
46.6
0.62
16
129
(3023410) Appearance of Cerebral spinal fluid
12
75
1.61
0.75
1.3
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
379
0.76
0.74
2.9
3.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
246
1.31
0.73
1.9
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
117
1.46
0.72
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
169
0.65
0.69
1.4
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
1.0
1.4
—
—
—
0
0
(4027681)
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
267
1.28
0.68
1.8
2.9
g/l
0.2
0.2
0.10
22
96
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
84
727
1.17
0.67
2.6
2.6
ug/l
4.9
6.3
0.67
73
637
(3021788) Differential panel - Synovial fluid
21
153
1.38
0.67
2.1
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
44
1.60
0.65
1.1
1.1
nmol/l
145.6
144.9
—
7
44
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
29
1.73
0.64
1.2
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
727
7128
1.13
0.63
4.7
4.7
mmol/l
1.5
1.5
0.62
686
6462
(3051611) Lipemic interference index of Serum or Plasma
12
79
1.53
0.63
3.6
3.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
104
0.57
0.62
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
49
1.64
0.62
1.4
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
49
1.64
0.62
1.9
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
88
1.48
0.61
1.7
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
26
201
1.30
0.59
2.2
1.6
e6/l
10618.4
17015.0
0.71
19
146
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
23
0.00
0.58
0.0
1.1
—
26.7
—
0
17
(3003338) MCHC [Mass/volume]
561
5777
0.92
0.58
34.5
21.3
g/l
330.0
331.5
3.55
556
5743
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
113
0.62
0.58
1.7
2.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
174
1602
1.11
0.57
2.1
1.8
nmol/l
1317.1
1208.6
0.84
137
1182
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
55
1.46
0.56
2.9
1.5
g/l
0.8
1.0
—
8
55
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
65
1.54
0.55
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
275
2595
1.09
0.54
5.6
5.5
ug/l
2.6
3.0
0.45
248
2307
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
61
1.48
0.54
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
533
0.84
0.53
2.8
3.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
40
1.50
0.51
1.5
2.7
u/ml
423.7
1281.8
—
6
40
(3019832) Treponema pallidum Ab [Presence] in Serum
37
307
1.21
0.50
1.3
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
41
346
1.19
0.47
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
117
0.68
0.46
1.3
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
86
1.40
0.44
1.0
1.1
u/ml
2.3
5.9
—
6
41
(3001019) Free T4 and TSH panel - Serum or Plasma
19
241
0.78
0.44
1.3
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
93
0.64
0.42
1.5
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
17
0.00
0.40
0.0
1.9
—
3.6
—
0
7
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
8
61
1.31
0.39
1.8
4.1
—
29.8
—
0
16
(3000093) Morphology [Interpretation] in Blood Narrative
9
68
1.33
0.37
1.2
1.2
—
—
—
0
0
(4024509)
10
72
1.39
0.37
2.2
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(4094501)
24
199
1.21
0.35
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
87
0.69
0.33
1.0
1.3
—
—
—
0
0
(44813793)
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
47
1.28
0.32
1.2
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
52
1.35
0.31
1.0
1.4
—
50.0
—
0
8
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
55
1.27
0.30
1.0
1.5
—
275.0
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
7
55
1.27
0.30
1.9
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
94
1.28
0.28
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
85
1.30
0.28
1.8
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
366
1.13
0.27
1.6
1.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
95
1.27
0.26
1.8
1.4
e6/l
31661.0
43538.8
—
6
49
(40768806) Pleura Pathology biopsy report
12
95
1.27
0.26
1.6
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(4306422)
10
77
1.30
0.26
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
72
1.25
0.25
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
13
105
1.24
0.25
1.7
1.4
e6/l
2537.0
1526.6
—
7
70
(21494434) Karyotype in Bone marrow
9
77
1.17
0.24
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
162
1.18
0.23
1.6
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
19
221
0.86
0.22
4.4
5.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
25.3
—
0
11
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
17.2
—
0
10
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
283
0.88
0.21
2.0
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
12
0.00
0.21
0.0
1.7
—
3.5
—
0
6
(3014891) Appearance of Pleural fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
48
1.25
0.20
3.0
3.2
—
39.6
—
0
12
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
51
1.18
0.19
3.2
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
81
1.24
0.19
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
367
1.09
0.18
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
60
1.17
0.18
1.6
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
61
1.15
0.17
2.3
1.4
u/l
46.9
33.9
—
7
50
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
183
0.87
0.16
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
225
1.11
0.16
2.0
2.5
ug/min
113.9
84.7
0.20
15
134
(4034850)
26
235
1.11
0.16
15.2
11.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
63
666
0.94
0.15
4.5
3.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
9
81
1.11
0.15
1.8
1.2
mmol/l
8.3
7.3
—
9
54
(3040151) Glucose [Moles/volume] in Capillary blood
7
90
0.78
0.14
2.7
5.7
mmol/l
6.9
7.1
—
7
71
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
237
1.10
0.14
2.1
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
132
1.14
0.13
2.4
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
44
1.14
0.10
1.2
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
47
1.06
0.09
2.4
3.6
—
—
—
0
0
(1002224) Polysomnography panel
21
227
0.92
0.09
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.0
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
60
0.83
0.08
1.0
1.0
u/ml
2.7
3.3
—
5
25
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
63
0.79
0.08
1.0
1.6
—
27.1
—
0
9
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
64
1.09
0.08
1.1
1.2
u/l
9.9
11.9
—
7
56
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
307
0.94
0.08
1.9
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
76
1.05
0.07
1.4
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.1
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
80
0.87
0.07
2.1
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
85
0.82
0.07
1.0
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
731
0.97
0.07
2.7
3.1
ng/l
207.0
210.9
0.03
63
674
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
92
0.87
0.06
1.1
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
93
0.86
0.06
4.1
3.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
94
0.85
0.06
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
94
0.85
0.06
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
95
0.84
0.06
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
95
0.84
0.06
1.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
100
0.90
0.06
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
18
193
0.93
0.06
1.6
1.2
u/ml
1.7
9.7
—
8
26
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
207
2093
0.99
0.05
4.6
4.7
%
21.5
21.4
0.04
105
1084
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
337
1.04
0.05
1.5
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
179
1.06
0.05
1.1
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
54
526
1.03
0.04
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
230
1.04
0.03
2.1
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
179
0.95
0.03
2.6
2.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
189
0.95
0.03
1.6
1.2
u/ml
2.7
2.8
—
6
19
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.4
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
51
504
1.01
0.00
3.6
3.7
ph
7.4
7.4
0.31
11
63
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
482
1.00
0.00
3.4
3.6
mmol/l
1.6
1.9
0.36
30
371
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
95
1.05
0.00
1.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
7.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
60
1.00
0.00
1.0
1.0
ng/l
211.5
267.3
—
6
34
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
60
1.00
0.00
1.0
1.0
ng/l
25.3
39.2
—
6
32
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.2
—
1.6
—
0
6
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
56
0.89
0.00
1.0
1.4
u/l
15.2
14.4
—
5
51
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
7.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
89
0.90
0.00
1.5
1.4
mmol/l
6.0
6.7
—
8
83
(4268621)
6
61
0.98
0.00
2.0
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
3.1
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_PANCREAS and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_PANCREAS 2.49 [2.03, 3.05] < 0.001
Birth year 0.996 [0.99, 1.0] 0.372

During the follow-up period (1.1.1998 — 31.12.2019), 488 out of 1662 females with CD2_BENIGN_PANCREAS died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_PANCREAS 3.362 [2.54, 4.46] < 0.001
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 427 out of 1130 males with CD2_BENIGN_PANCREAS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_PANCREAS.

N-year risk Females Males
1 0.271% 0.774%
5 1.715% 4.164%
10 4.112% 9.607%
15 7.39% 17.252%
20 12.905% 28.711%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_PANCREAS – Benign neoplasm: Pancreas

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data